Northern Trust Corp Buys 258,580 Shares of Nano-X Imaging Ltd. (NASDAQ:NNOX)

Northern Trust Corp grew its position in shares of Nano-X Imaging Ltd. (NASDAQ:NNOX - Free Report) by 71.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 621,365 shares of the company's stock after acquiring an additional 258,580 shares during the quarter. Northern Trust Corp owned 1.08% of Nano-X Imaging worth $4,474,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently bought and sold shares of the company. US Bancorp DE boosted its holdings in shares of Nano-X Imaging by 388.7% in the 4th quarter. US Bancorp DE now owns 3,470 shares of the company's stock worth $25,000 after buying an additional 2,760 shares during the last quarter. Quadrant Capital Group LLC lifted its stake in Nano-X Imaging by 464.9% in the 4th quarter. Quadrant Capital Group LLC now owns 7,016 shares of the company's stock worth $51,000 after purchasing an additional 5,774 shares in the last quarter. Quantum Private Wealth LLC purchased a new stake in shares of Nano-X Imaging during the 4th quarter valued at $72,000. Signaturefd LLC raised its position in shares of Nano-X Imaging by 164.6% during the 4th quarter. Signaturefd LLC now owns 10,391 shares of the company's stock valued at $75,000 after buying an additional 6,464 shares in the last quarter. Finally, Kingsview Wealth Management LLC purchased a new stake in shares of Nano-X Imaging during the 4th quarter valued at $94,000. 21.49% of the stock is owned by hedge funds and other institutional investors.

Nano-X Imaging Price Performance

NASDAQ NNOX traded up $0.05 during trading hours on Tuesday, reaching $5.18. 1,317,575 shares of the company's stock traded hands, compared to its average volume of 1,738,481. The firm has a market cap of $299.30 million, a PE ratio of -6.09 and a beta of 2.03. Nano-X Imaging Ltd. has a 52-week low of $3.75 and a 52-week high of $11.00. The firm has a 50-day simple moving average of $5.08 and a 200 day simple moving average of $6.33.

Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last issued its earnings results on Thursday, May 22nd. The company reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.02. The business had revenue of $3.00 million during the quarter, compared to analysts' expectations of $3.98 million. Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%. Sell-side analysts forecast that Nano-X Imaging Ltd. will post -0.92 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Alliance Global Partners reissued a "buy" rating on shares of Nano-X Imaging in a report on Thursday, May 22nd. Cantor Fitzgerald cut their price target on shares of Nano-X Imaging from $12.00 to $9.00 and set an "overweight" rating on the stock in a report on Tuesday, April 1st. Finally, D. Boral Capital cut their price target on shares of Nano-X Imaging from $15.00 to $10.00 and set a "buy" rating on the stock in a report on Friday.

About Nano-X Imaging

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.